Semaglutide as a Pharmacological Strategy for Weight Management Semaglutide, approved for the treatment of obesity in 2021, is a GLP-1RAa class of peptide-based drugs that mimic the effects of the endogenous incretin hormone glucagon-like peptide-1 (GLP-1) [9, 28]
Moreover, in STEP 8 [46], semaglutide 2.4 mg exhibited superior efficacy compared with liraglutide 3.0 mg, achieving a mean reduction in BW of more than 10%
"Because Im not starving, I can actually stop and make a smarter decision [rather] than, 'Oh my God, Im ravenous
The SHAPE real-world study found 83.5% of semaglutide users reached 2.4 mg versus only 25.9% of tirzepatide users at 15 mg, and outcomes still favored tirzepatide
We've helpedmore than 300,000clients shedover 3MILLION unwanted pounds and improve their health and wellness with our doctor approved and recommended weight loss program
Does Wegovy interfere with how ADHD medication works? Wegovy does not reduce the efficacy or bioavailability of stimulant ADHD medications, but it does delay their absorption